Kanthasudharak Vati: Benefits, Evidence & Safety

TL;DR

Kanthasudharak Vati is a proprietary Ayurvedic throat lozenge based on licorice (~57% of the formula) with camphor, cardamom, clove and mace, traditionally sucked for sore throat, hoarseness and cough. The strongest related evidence is a 2019 meta-analysis of 5 RCTs (n=609) finding topical licorice reduced postoperative sore throat incidence (RR 0.44): not a trial of this lozenge itself. (59 words. Sources: Dawaghar product data; Kuriyama & Maeda 2019)

What it is

Kanthasudharak Vati (also sold as Kanth Sudhark Vati or Kantha Sudharak Bati) is a proprietary Ayurvedic throat lozenge made by manufacturers such as Unjha and Baidyanath: it is not a classical Ayurvedic Formulary of India preparation with a single fixed recipe, so the composition below is manufacturer-specific (Dawaghar product information, 1mg product listing). The Unjha formula per pill: licorice concentrate (Glycyrrhiza glabra, ~57%), mace (Myristica fragrans, ~16%), camphor (Cinnamomum camphora, ~8%), cardamom (Elettaria cardamomum, ~8%), clove (Syzygium aromaticum, ~8%), peppermint (~2%) and saccharin (Dawaghar). Baidyanath's version lists the same core botanicals: licorice, peppermint, camphor, cardamom, clove and nutmeg/mace (The MG Shop product page). It is meant to be sucked slowly, not swallowed whole.

Traditional use

Manufacturer labelling positions Kanthasudharak Vati for sore throat, hoarseness of voice, cough, bad breath and excess stickiness/kapha in the mouth. Baidyanath's literature describes it as vat-kapha samak and swas-kas-har (pacifying vata-kapha; relieving breathlessness and cough), claiming licorice's demulcent, soothing and expectorant action helps singers' voice quality (Dawaghar, The MG Shop). These are traditional/manufacturer claims: they have not been validated in clinical trials of the lozenge itself.

What modern research says

No human trials of Kanthasudharak Vati itself were located. The most relevant modern evidence is for topical licorice, its main ingredient: a 2019 systematic review and meta-analysis by Kuriyama & Maeda (J Clin Anesth) pooled 5 RCTs (609 patients) and found topical licorice reduced the incidence (risk ratio 0.44, 95% CI 0.28–0.69, p<0.001) and severity of postoperative sore throat, with trial-sequential analysis confirming adequate evidence and no significant adverse events reported (Kuriyama et al. meta-analysis). A network meta-analysis of 70 RCTs (7,141 patients) similarly ranked topical liquorice among the most effective agents for preventing postoperative sore throat at 24 hours (OR 0.14, 95% CrI 0.03–0.55) (Singh et al. network meta-analysis). A 2024 double-blind RCT (n=126) found licorice gargle did not meaningfully reduce pain or morphine use after oropharyngeal surgery, showing the benefit is not universal across throat-pain settings (MDPI J Pers Med 2024). Note: these studies tested licorice gargles/lozenges in surgical patients: related, but not proof that this commercial vati works for everyday sore throat.

Safety & contraindications

Licorice (glycyrrhizin) first: the lozenge's main ingredient carries real safety caveats. NCCIH notes that glycyrrhizin in licorice can cause serious effects, irregular heartbeat and cardiac arrest, especially with large amounts or long-term use, and even small amounts have been linked to severe effects in people with hypertension or heart/kidney conditions. Licorice also interacts with corticosteroids, and large amounts in pregnancy are unsafe (NCCIH: Licorice Root). A single lozenge sucked occasionally is a far smaller exposure than the risky doses, but frequent daily use (the label suggests 1–2 pills, 5–6 times a day) should not continue indefinitely without medical advice. Pregnancy/breastfeeding/children: seller guidance advises consulting a doctor if pregnant or breastfeeding, and keeping the product out of reach of children (dawaadost medicine page). Other cautions: people with hypertension, heart rhythm problems, kidney disease or low potassium should be cautious with any licorice-containing product. Do not exceed the label's dose, and do not use it if allergic to any ingredient (NCCIH, dawaadost).

FAQs

Q: What is Kanthasudharak Vati used for? A: It is a throat lozenge manufacturers market for sore throat, hoarseness, cough, bad breath and excess mouth stickiness, traditionally sucked slowly so the herbs coat the throat. These are manufacturer and traditional claims; no clinical trial of the lozenge itself exists (Dawaghar).

Q: What are its main ingredients? A: Licorice concentrate (about 57% of the Unjha formula), mace/nutmeg, camphor, cardamom, clove and peppermint, sweetened with saccharin. Because it is a proprietary product, the exact recipe differs between manufacturers such as Unjha and Baidyanath (Dawaghar).

Q: Does science support it for sore throat? A: Indirectly at best. A 2019 meta-analysis of 5 RCTs found topical licorice cut postoperative sore throat incidence (RR 0.44), and a 70-trial network meta-analysis ranked it highly. But no study has tested this lozenge for everyday sore throat, so efficacy is unproven (Kuriyama et al.).

Q: How is it used? A: The label directs sucking 1–2 pills, 5–6 times a day, rather than swallowing them. Use it for short-term symptom relief and follow the label or your practitioner's advice; do not take more than directed (Dawaghar).

Q: Is it safe in pregnancy? A: Seller guidance says to consult a doctor if you are pregnant or breastfeeding before using it. NCCIH additionally warns that large amounts of oral licorice in pregnancy are unsafe (increased risk of early delivery), so err on the side of medical advice (dawaadost, NCCIH).

Q: Who should be cautious with it? A: People with high blood pressure, heart rhythm disorders, kidney disease, or low potassium, and anyone taking diuretics, corticosteroids, digoxin or warfarin, should be cautious with licorice-containing products and seek medical advice first, since glycyrrhizin can disturb electrolytes and blood pressure (NCCIH).

Q: What is the correct dose? A: No dose appears in the Ayurvedic Pharmacopoeia of India or any clinical trial for this proprietary lozenge, so none is given here. The commercial label suggests 1–2 pills sucked 5–6 times daily; do not exceed it, and ask a practitioner about prolonged use (Dawaghar).

Sources

Tier 1 (classical / pharmacopoeial / peer-reviewed):

Tier 2 (PubMed-indexed):

Tier 3 (product labels — cited as such):

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation.